Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 24, 2026
SCHD vs SCHV: Weighing Dividend Quality Against Broad Value Exposure

SCHD vs SCHV: Weighing Dividend Quality Against Broad Value Exposure

Key Takeaways

  • Different mandates: SCHD targets high-quality, dividend-paying U.S. equities, while SCHV provides broad exposure to the large-cap value segment of the U.S. market.
  • Holdings breadth: SCHD holds roughly 100–102 names versus approximately 560–570 for SCHV, giving SCHV materially greater diversification.
  • Cost structure: Both are low-cost, passively managed funds, with SCHV charging 0.04% and SCHD charging 0.06% in annual expenses.
  • Sector profile: SCHD leans toward consumer staples, healthcare, and energy, while SCHV skews toward financials, technology, and industrials.
  • Income orientation: SCHD is built around dividend durability and yield, whereas SCHV prioritizes valuation characteristics across the large-cap value universe.
  • Risk and positioning: SCHD is more concentrated and income-driven; SCHV is broader and more diversified, with different sensitivity to sector rotation and interest-rate expectations.

Why These Two Schwab ETFs Often Come Up Together

Investors looking for value and income exposure often find themselves comparing SCHD and SCHV, two low-cost ETFs from the same provider that share a defensive, value-oriented tilt yet approach it differently. They are not direct substitutes: SCHD follows a dividend-quality strategy, while SCHV offers broad large-cap value coverage. In my view, understanding their structural differences matters now because sector rotation, interest-rate expectations, and the back-and-forth between growth and value have made relative positioning important. This comparison looks at index construction, sector exposure, cost, and risk to help clarify which fund may better align with different objectives.

SCHD: A Dividend-Quality Approach

SCHD tracks the Dow Jones U.S. Dividend 100 Index, a market-capitalization-weighted benchmark that selects roughly 100 U.S. companies with strong dividend records, sustainable payout fundamentals, and quality traits such as cash flow and profitability. The fund is passively managed and rebalances periodically. It typically holds around 100–102 stocks, with larger positions including Texas Instruments (TXN), Qualcomm (QCOM), Procter & Gamble (PG), Chevron (CVX), Coca-Cola (KO), Merck (MRK), UnitedHealth Group (UNH), and ConocoPhillips (COP). Sector allocation concentrates in consumer staples, healthcare, technology, and energy. The expense ratio sits at 0.06%. Its core feature is a deliberate focus on durable dividend payers rather than broad value exposure. From what I see, this makes SCHD particularly relevant when income stability is a priority.

SCHV: Broad Large-Cap Value Coverage

SCHV tracks the Dow Jones U.S. Large-Cap Value Total Stock Market Index, a float-adjusted, market-cap-weighted index covering the large-cap value portion of the U.S. equity market. The fund is passively managed and holds approximately 560–570 stocks, providing broad diversification with limited single-stock concentration. Top holdings include Berkshire Hathaway (BRK-B), JPMorgan Chase (JPM), ExxonMobil (XOM), Johnson & Johnson (JNJ), Intel (INTC), Walmart (WMT), AbbVie (ABBV), and Cisco Systems (CSCO). Sector exposure leads with financials, followed by technology, healthcare, industrials, and consumer staples. Its expense ratio of 0.04% ranks among the lowest in the category. Because it captures the full value segment, SCHV delivers wider factor exposure but a lower, less yield-focused dividend profile than SCHD.

Market Backdrop Shaping Both Funds

Both funds sit within the value and income segment of the U.S. equity market, an area influenced in recent cycles by Federal Reserve policy, inflation trends, and the ongoing rotation between growth and value styles. Higher-for-longer interest rates have supported financial-sector earnings while pressuring rate-sensitive defensive stocks. Energy and healthcare, key pillars for SCHD, continue to respond to commodity prices, regulatory shifts, and demographic demand. SCHV’s heavier weighting in financials and semiconductors ties its results more closely to credit conditions, capital-markets activity, and cyclical technology hardware recovery. Sustained interest in low-cost passive vehicles has supported inflows into both, even as sector leadership rotates.

Performance and Positioning: What Stands Out

In recent periods, relative performance has largely followed sector leadership. SCHD’s concentration in consumer staples, healthcare, and energy has delivered more defensive characteristics, while its technology allocation has allowed some participation in broader rallies. SCHV’s wider footprint, anchored by financials, industrials, and technology, has created greater sensitivity to cyclical reflation and earnings cycles at large banks and semiconductor companies. As a result, SCHV has tended to carry a slightly higher beta to the overall market than SCHD, while SCHD’s emphasis on cash-flow-rich dividend payers has historically produced lower structural volatility and a higher distribution yield. Investors choosing between the two are essentially selecting between targeted income quality and broad value diversification. I also checked this using Tickeron’s AI Screener to see how the funds compare to others in the category.

Tickeron AI Assessment

Based on observable structural factors, Tickeron’s AI would likely favor SCHD in environments that reward defensiveness, income durability, and lower volatility, given its disciplined quality screen and concentrated exposure to cash-generative sectors. Conversely, the model would likely lean toward SCHV when broad value, diversification, and cyclical momentum are more rewarded, reflecting its wider holdings base and lower cost. On balance, the assessment would hinge on prevailing trend consistency and sector momentum: if defensive and income-oriented leadership persists, SCHD may hold the edge; if a broad-based value and cyclical rotation dominates, SCHV’s diversification and 0.04% cost advantage could make it the more favorable candidate. Neither outcome constitutes a recommendation, and positioning should be evaluated against each investor’s goals and risk tolerance.

Using Tickeron’s AI Screener for ETF Comparisons

In my own research process I turn to Tickeron’s AI Screener when I want to filter ETFs and stocks by technical patterns, fundamentals, and AI-driven signals. It lets me scan thousands of names with customizable criteria and quickly surface ideas that align with a particular thesis, which proved helpful when weighing SCHD against SCHV.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD, SCHV

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


Momentum Indicator for SCHD turns positive, indicating new upward trend

SCHD saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In 73 of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SCHD just turned positive on October 09, 2026. Looking at past instances where SCHD's MACD turned positive, the stock continued to rise in 39 of 46 cases over the following month. The odds of a continued upward trend are 85%.

SCHD moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.

Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 269 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

SCHD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SCHD entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Unitedhealth Group (NYSE:UNH), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), QUALCOMM (NASDAQ:QCOM), Verizon Communications (NYSE:VZ).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 58.71B. The market cap for tickers in the group ranges from 415.95M to 457.47B. CVX holds the highest valuation in this group at 457.47B. The lowest valued company is OXM at 415.95M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 3%. For the same ETF, the average monthly price growth was 6%, and the average quarterly price growth was 15%. RHI experienced the highest price growth at 38%, while MSM experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -7%. For the same stocks of the ETF, the average monthly volume growth was 11% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 42
Price Growth Rating: 44
SMR Rating: 42
Profit Risk Rating: 57
Seasonality Score: 42 (-100 ... +100)
View a ticker or compare two or three
SCHD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeValue

Category
Large Value
Address
Schwab Strategic Trust101 Montgomery StreetSan Francisco
Phone
1-800-435-4000
Web
www.csimfunds.com.
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.